A GLOW vial is 14 percent BPC-157. That’s 10mg out of 70mg, with the rest split between 50mg of GHK-Cu and 10mg of TB-500. It’s a useful number to hold in mind, because the GLOW peptide vs BPC-157 question usually arrives as if the blend were an upgraded version of the single compound, and by mass it’s mostly something else. This comparison covers what each product contains, what the research behind the other two compounds covers, what the batch certificates show, and when a single compound or a blend makes the cleaner study. Everything below describes laboratory research. The listings are linked as we go, and the peptides for healing category shows the neighboring compounds.
GLOW peptide vs BPC-157: what is the difference?
BPC-157 is one compound: a 15 amino acid peptide derived from a protein in gastric juice, studied for blood vessel formation and tissue repair. GLOW 70 is a three-compound vial holding 50mg of GHK-Cu, 10mg of BPC-157 and 10mg of TB-500. Both contain the same 10mg of BPC-157. What GLOW adds is a copper peptide studied for skin remodeling and collagen, and a fragment of thymosin beta-4 studied for cell migration. Whether the three do anything together that BPC-157 doesn’t do alone hasn’t been tested in any paper cited on this page.
GLOW peptide vs BPC-157 side by side
The table covers the fixed facts, plus size, price and batch data pulled live from the product and certificate pages. Searching glow peptide vs bpc 157 or bpc 157 vs glow blend gives the same two columns.
| BPC-157 | GLOW 70 | |
|---|---|---|
| What is in the vial | BPC-157 only | GHK-Cu 50mg, BPC-157 10mg, TB-500 10mg |
| BPC-157 per vial | 10mg, all of it | 10mg, about 14 percent of the vial |
| Number of compounds | 1 | 3 |
| Main research areas | Blood vessel formation, tendon, ligament, muscle and gut lining models | Those, plus collagen and skin remodeling and cell migration |
| Size at Healio Peptides | 10mg | 70mg |
| Price per vial | $59.99 | $104.99 |
| Latest batch purity (HPLC) | 99.5% | 99.3% |
| Certificate | BPC-157 COA | GLOW 70 COA |
What BPC-157 alone covers in research
BPC-157 stands for Body Protection Compound 157. The best single source is a 2025 systematic review in HSS Journal by Vasireddi and colleagues, who kept 36 studies out of 544 articles. Thirty-five were preclinical and one was a small retrospective clinical report. The consistent animal findings, in angiogenesis and growth pathways and in lower inflammatory cytokines, are what the BPC-157 half of any GLOW argument rests on. See what BPC-157 does in research for the mechanism in plain language.
What the rest of GLOW adds
Two compounds share the vial. GHK-Cu is a copper tripeptide with the longest record of the three, and a 2018 review in the International Journal of Molecular Sciences covers its regenerative and protective actions. It accounts for 50mg of the vial. TB-500 is a synthetic fragment of thymosin beta-4, studied for actin binding and cell migration, with a 2010 FASEB Journal review explaining where the idea of a short active fragment comes from. The GLOW peptide benefits guide takes the three compounds one at a time.
How the 50:10:10 ratio shapes the comparison
The ratio is a design decision, and it matters here. GLOW 70 is 50mg of GHK-Cu to 10mg each of BPC-157 and TB-500, so the copper peptide is present at five times either of the other two. Dissolve the vial in any volume of water and the GHK-Cu concentration is five times the BPC-157 concentration, which is arithmetic and not a research finding. A study that wanted BPC-157 and GHK-Cu at equal concentrations couldn’t use this vial, and one that wanted them at five to one could. A pair of separate vials gives control over the ratio, and a blend gives convenience at a fixed one. The GLOW calculator shows the numbers for any water volume.
GLOW peptide vs BPC-157 for skin and repair research
The two products point at different tissues. GHK-Cu, the bulk of GLOW, is the compound with the long skin and collagen record. BPC-157 is the one with the animal repair record in tendon, ligament and gut models. So a skin remodeling question tilts toward the blend because of its GHK-Cu, and a pure BPC-157 question tilts toward the single vial. A comparison that says GLOW “contains BPC-157 plus more” is accurate and incomplete, since the more is most of the vial.
BPC-157 vs GLOW: the attribution problem
Run a study with BPC-157 alone and any change points at one compound. Run it with GLOW and the change could come from any of the three, or from an interaction. Because 71 percent of the vial is GHK-Cu, a skin or collagen effect would more plausibly trace to the copper peptide than to the BPC-157, which makes up 14 percent and sits beside TB-500 at the same 10mg. So the answer to “does GLOW work better than BPC-157” depends entirely on the outcome measured, and no published result addresses the blend itself. A result from the blend can’t be set against the BPC-157 literature without a caveat, since those papers used the compound alone.
When BPC-157 alone is the cleaner design
A baseline study, a replication, or a mechanism question in a tendon, ligament or gut model wants one variable. The single-compound vial gives it, and the result can be compared directly with the published BPC-157 papers. For a design focused on repair, the other 60mg in a GLOW vial is material the study didn’t ask for.
When a blend makes sense
GLOW suits a design that wants several mechanisms at once: repair, collagen remodeling and cell migration, in one reconstitution, with the 50:10:10 ratio accepted as fixed. It also cuts handling, since one vial replaces three. Those are fair practical reasons, and they leave the attribution problem intact, so a careful design would add single-compound arms alongside it. The GHK-Cu vs GLOW page looks at the same blend from the copper peptide side.
What the BPC-157 and GLOW studies can’t tell you
Most of the repair literature was built on male animals, and results often weren’t broken out by sex. That’s a gap for anyone reading across to a woman’s research question, and the BPC-157 research gap in women covers it. The papers also use different models, routes and schedules, and none tests the three GLOW compounds together. Every statement about the blend borrows from three separate literatures.
One vial or three: handling compared
Buying the three compounds as separate vials means three reconstitutions and three sets of arithmetic. GLOW means one. Each vial dissolves in bacteriostatic water for sale, added slowly down the vial wall with no shaking, and how to reconstitute peptides covers the handling. The trade is the one already named: separate vials keep each concentration independent, and the blend fixes them. Neither is more rigorous in itself. Rigor comes from the controls around the experiment.
BPC-157 and GLOW COA: what a lab report shows
Every Healio Peptides batch is tested by an independent US laboratory before release, and the report is published before you order. These are the current two.
| BPC-157 | GLOW 70 | |
|---|---|---|
| Batch | HEALIO-BPC157-2605 | HEALIO-GLOW70-2617 |
| Purity (HPLC) | 99.5% | 99.3% |
| Identity (ESI-MS) | Confirmed, conforms to the reference standard (1419.56) | Confirmed for each component |
| Endotoxins (LAL) | Under 0.5 EU/mg (limit 5 EU/mg) | Under 0.5 EU/mg (limit 5 EU/mg) |
The identity line reads differently for each. On the BPC-157 report it matches one compound to a reference standard. On GLOW it confirms every component is present, which is the check that matters for a blend, because a single purity percentage can’t say whether the mix is right. Match batch and lot numbers to the vial. Reading a peptide certificate of analysis explains each row.
GLOW peptide vs BPC-157 price and format
BPC-157 is $59.99 for a 10mg vial, and GLOW 70 is $104.99 for the 70mg vial. The extra 60mg in GLOW is the other two compounds. Priced as separate vials at their lowest listed sizes, all three come to $169.97, so GLOW 70 is 38% lower than buying the contents one by one. The sums are calculated live from the listed prices. Both reconstitute with bacteriostatic water for sale, and the BPC-157 calculator and GLOW calculator turn vial strength and water volume into a concentration.
Where to buy BPC-157 and GLOW for research
With either product, look for a published certificate before anything else. Every Healio Peptides batch ships with a third-party report, and orders go out from the United States. The single compound is the BPC-157 listing, and the three-compound vial is the GLOW 70 listing.
BPC-157 vs GLOW: frequently asked questions
Is GLOW better than BPC-157?
Neither wins on the evidence. GLOW broadens the question with two more compounds, and BPC-157 alone keeps the question narrow and the result attributable. The better choice follows from what a study measures.
Does GLOW contain BPC-157?
Yes. Each GLOW 70 vial holds 10mg of BPC-157, the same amount as the single-compound vial, plus 50mg of GHK-Cu and 10mg of TB-500.
How much of GLOW is BPC-157?
About 14 percent by mass, 10mg of 70mg. The largest component is GHK-Cu at about 71 percent.
Can BPC-157 be studied on its own rather than in GLOW?
Yes. BPC-157 is its own listing, and studying it alone keeps any result tied to one compound. The GLOW vs Wolverine stack page covers the repair pair on its own.
Are BPC-157 and GLOW FDA approved?
Neither is approved as a drug for human use, and both sit almost entirely in animal and cell research. Nothing on this page is medical advice, and Healio Peptides sells both for laboratory research only.
How does BPC-157 vs GLOW compare with BPC-157 vs KLOW?
KLOW is GLOW with 10mg of KPV added, which takes BPC-157’s share down to 12.5 percent. The BPC-157 vs KLOW page covers that step.
More on BPC-157 and GLOW
- BPC-157 vs GHK-Cu, the two compounds without the blend around them.
- GLOW vs KLOW, the two blends differ by exactly one compound.
- BPC-157 vs the Wolverine stack, one compound against the repair pair.
Healio Peptides supplies research compounds for laboratory use only. They are not for human or veterinary use, have not been evaluated by the FDA, and nothing on this page is medical advice.
BPC-157
GLOW Peptide Blend